Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects

BACKGROUND: Phosphodiesterase 4 (PDE4) inhibitors increase intracellular cyclic adenosine monophosphate (cAMP), leading to regulation of inflammatory cell functions. Roflumilast is a potent and targeted PDE4 inhibitor. The objective of this study was to evaluate the effects of roflumilast on broncho...

詳細記述

保存先:
書誌詳細
主要な著者: Gauvreau, Gail M, Boulet, Louis-Philippe, Schmid-Wirlitsch, Christine, Côté, Johanne, Duong, MyLinh, Killian, Kieran J, Milot, Joanne, Deschesnes, Francine, Strinich, Tara, Watson, Richard M, Bredenbröker, Dirk, O'Byrne, Paul M
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2011
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219708/
https://ncbi.nlm.nih.gov/pubmed/22029856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-12-140
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料